United Therapeutics

UTHR · NASDAQ

$553.88+$10.73 (+1.98%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $543.15

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. The company is headquartered in Silver Spring, Maryland and currently employs 1,400 full-time employees. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Employees: 1,400
Headquarters: Silver Spring, Maryland
Listed: Jun 17, 1999
Sector: Health Care
Industry: Biotechnology
Website: unither.com

Leadership

United Therapeutics executives
Name	Title	Since	Age
Martine Rothblatt	—	1996	70
Michael Benkowitz	—	—	53
Christopher Patusky	—	—	61
James Edgemond	—	—	58
Paul Mahon	—	—	61
Jan Malcolm	—	—	68
Kevin Tracey	—	—	—
Christopher Causey	—	—	62
Prof. Raymond Dwek	—	—	83
Richard Giltner	—	—	61
Raymond Kurzweil	—	—	77
Linda Maxwell	—	—	51
Prof. Nilda Mesa	—	—	65
Judy Olian	—	—	73
The Hon. Dr. Louis Sullivan	—	—	91
Gov. Thomas Thompson	—	—	82

Revenue by product and region

Fiscal year ended Dec 31, 2025: $3.18B total revenue

By product

Unituxin$226.80M7.1%
Adcirca$30.00M0.9%

By region

United States$3.04B95.4%
Rest-of-World$145.70M4.6%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

United Therapeutics suppliers and customers
Company	Relationship	Country	Correlation
Medtronic plc MDT	Supplier	—	0.90
AmerisourceBergen Corporation ABC	Supplier	—	0.87
CVS Health Corporation CVS	Customer	—	0.82
Eli Lilly and Company LLY	Supplier	—	0.78
MannKind Corporation MNKD	Supplier	—	0.77
Catalent, Inc. CTLT	Supplier	—	0.74
Supernus Pharmaceuticals, Inc. SUPN	Supplier	—	0.69
Veeva Systems Inc. VEEV	Supplier	—	0.27
Baxter International Inc. BAX	Supplier	—	0.25
Mochida Pharmaceutical Co., Ltd.	Customer	—	-0.40

Similar companies

Companies in the same industry as United Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.